Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Leukemia 21Lymphoma 7Burkitt Lymphoma 6Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Anemia, Refractory, with Excess of Blasts 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Down Syndrome 2Anemia, Refractory 2Sarcoma, Myeloid 1Recurrence 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Basophilic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Cardiotoxicity 1

Interventions

Dexamethasone 28Rituximab 16pomalidomide 14Gemcitabine 12Bortezomib 12Lenalidomide 11Cisplatin 11Paclitaxel 10Cyclophosphamide 8Carboplatin 8carfilzomib 7daratumumab 6selinexor 5Drug Therapy 5Doxorubicin 5Cytarabine 5ibrutinib 4Vincristine 4Temozolomide 4Prednisone 4Docetaxel 4Calcium Dobesilate 4Bevacizumab 4Aspirin 4tisagenlecleucel 3Injections 3Cetuximab 3Bendamustine Hydrochloride 3venetoclax 2ofatumumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Recurrence × Asparaginase × Clear all
NCT03623087 2018-08-14

SIMPLE Chemotherapy for NK Lymphoma/Leukaemia

The University of Hong Kong

Phase 3 Unknown
68 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡